JO
FRTX

John Overdeck’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

John Overdeck’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,351
Closed -$24K – 4662
2021
Q4 		$24K Buy
2,351
+349
+17% +$6.27K ﹤0.01% 4168
2021
Q3 		$65K Buy
2,002
+1,471
+277% +$47.7K ﹤0.01% 4130
2021
Q2 		$23K Sell
531
-1,098
-67% -$45.1K ﹤0.01% 3955
2021
Q1 		$80K Buy
+1,629
New +$89.5K ﹤0.01% 3717
2019
Q3 		– Sell
-96
Closed -$26K – 3884
2019
Q2 		$26K Sell
96
-2
-2% -$670 ﹤0.01% 3259
2019
Q1 		$37K Hold
98
– – ﹤0.01% 2949
2018
Q4 		$36K Sell
98
-34
-26% -$13.3K ﹤0.01% 2875
2018
Q3 		$57K Hold
132
– – ﹤0.01% 3098
2018
Q2 		$48K Sell
132
-6
-4% -$2.83K ﹤0.01% 3236
2018
Q1 		$63K Buy
138
+18
+15% +$8.94K ﹤0.01% 3060
2017
Q4 		$69K Buy
+120
New +$79.1K ﹤0.01% 3019
2016
Q2 		– Sell
-4
Closed -$5K – 3318
2016
Q1 		$5K Sell
4
-11
-73% -$12.7K ﹤0.01% 2742
2015
Q4 		$19K Sell
15
-3
-17% -$3.91K ﹤0.01% 2630
2015
Q3 		$26K Sell
18
-29
-62% -$56K ﹤0.01% 2111
2015
Q2 		$103K Buy
47
+33
+236% +$103K ﹤0.01% 2711
2015
Q1 		$43K Sell
14
-31
-69% -$99.2K ﹤0.01% 2586
2014
Q4 		$150K Sell
45
-2
-4% -$7.08K ﹤0.01% 2095
2014
Q3 		$167K Sell
47
-10
-18% -$38.9K ﹤0.01% 1625
2014
Q2 		$219K Buy
57
+51
+850% +$192K ﹤0.01% 1948
2014
Q1 		$26K Sell
6
-13
-68% -$58K ﹤0.01% 1933
2013
Q4 		$71K Buy
19
+16
+533% +$60.6K ﹤0.01% 2104
2013
Q3 		$13K Buy
+3
New +$22.5K ﹤0.01% 1799

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return

John Overdeck's FRTX Position: Q1 2022 in Review

John Overdeck sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2022, closing a stake of 2,351 shares — an estimated $24K sold.

John Overdeck first reported a position in FRTX in Q3 2013 and held it in 22 quarters. The position peaked at $219K in Q2 2014. 22 funds tracked by Wall St. Rank hold FRTX as of Q1 2022.

  • John Overdeck reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 2,351 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $24K.
  • John Overdeck first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and held it in 22 quarters.
  • John Overdeck's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $219K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.